Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines

被引:41
作者
Nogales, Aitor [1 ]
DeDiego, Marta L. [1 ,2 ]
Topham, David J. [1 ,2 ]
Martinez-Sobrido, Luis [1 ]
机构
[1] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA
[2] Univ Rochester, David Smith Ctr Immunol & Vaccine Biol, Rochester, NY USA
关键词
A VIRUS; MESSENGER-RNA; M1; PROTEIN; M2; B VIRUS; REPLICATION; CHANNEL; PREVENTION; PROTECTION; MECHANISM;
D O I
10.1128/JVI.00410-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Influenza viral infections represent a serious public health problem, with influenza virus causing a contagious respiratory disease which is most effectively prevented through vaccination. Segments 7 (M) and 8 (NS) of the influenza virus genome encode mRNA transcripts that are alternatively spliced to express two different viral proteins. This study describes the generation, using reverse genetics, of three different recombinant influenza A/Puerto Rico/8/1934 (PR8) H1N1 viruses containing M or NS viral segments individually or modified M or NS viral segments combined in which the overlapping open reading frames of matrix 1 (M1)/M2 for the modified M segment and the open reading frames of nonstructural protein 1 (NS1)/nuclear export protein (NEP) for the modified NS segment were split by using the porcine teschovirus 1 (PTV-1) 2A autoproteolytic cleavage site. Viruses with an M split segment were impaired in replication at nonpermissive high temperatures, whereas high viral titers could be obtained at permissive low temperatures (33 degrees C). Furthermore, viruses containing the M split segment were highly attenuated in vivo, while they retained their immunogenicity and provided protection against a lethal challenge with wild-type PR8. These results indicate that influenza viruses can be effectively attenuated by the rearrangement of spliced segments and that such attenuated viruses represent an excellent option as safe, immunogenic, and protective live-attenuated vaccines. Moreover, this is the first time in which an influenza virus containing a restructured M segment has been described. Reorganization of the M segment to encode M1 and M2 from two separate, nonoverlapping, independent open reading frames represents a useful tool to independently study mutations in the M1 and M2 viral proteins without affecting the other viral M product.
引用
收藏
页码:6291 / 6302
页数:12
相关论文
共 50 条
  • [21] Development of live attenuated influenza vaccines against pandemic influenza strains
    Coelingh, Kathleen L.
    Luke, Catherine J.
    Jin, Hong
    Talaat, Kawsar R.
    [J]. EXPERT REVIEW OF VACCINES, 2014, 13 (07) : 855 - 871
  • [22] Live attenuated influenza virus vaccines by computer-aided rational design
    Mueller, Steffen
    Coleman, J. Robert
    Papamichail, Dimitris
    Ward, Charles B.
    Nimnual, Anjaruwee
    Futcher, Bruce
    Skiena, Steven
    Wimmer, Eckard
    [J]. NATURE BIOTECHNOLOGY, 2010, 28 (07) : 723 - U1729
  • [23] Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein
    Cheng, Benson Y. H.
    Nogales, Aitor
    de la Torre, Juan Carlos
    Martinez-Sobrido, Luis
    [J]. VIROLOGY, 2017, 501 : 35 - 46
  • [24] Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu
    Solorzano, Alicia
    Ye, Jianqiang
    Perez, Daniel R.
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (09) : 4587 - 4596
  • [25] Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells
    Forero, Adriana
    Fenstermacher, Katherine
    Wohlgemuth, Nicholas
    Nishida, Andrew
    Carter, Victoria
    Smith, Elise A.
    Peng, Xinxia
    Hayes, Melissa
    Francis, Doreen
    Treanor, John
    Morrison, Juliet
    Klein, Sabra L.
    Lane, Andrew
    Katze, Michael G.
    Pekosz, Andrew
    [J]. VACCINE, 2017, 35 (45) : 6112 - 6121
  • [26] Thoughts on the research of African swine fever live-attenuated vaccines
    Chu, Xuefei
    Ge, Shengqiang
    Zuo, Yuanyuan
    Cui, Jin
    Sha, Zhou
    Han, Naijun
    Wu, Bingrong
    Ni, Bo
    Zhang, Hui
    Lv, Yan
    Wang, Zhiliang
    Xiao, Yihong
    [J]. VACCINE, 2024, 42 (25)
  • [27] Recent progress on gene-deleted live-attenuated African swine fever virus vaccines
    Vu, Hiep L. X.
    Mcvey, D. Scott
    [J]. NPJ VACCINES, 2024, 9 (01)
  • [28] Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines
    Crafford, J. E.
    Lourens, C. W.
    Smit, T. K.
    Gardner, I. A.
    MacLachlan, N. J.
    Guthrie, A. J.
    [J]. VACCINE, 2014, 32 (29) : 3611 - 3616
  • [29] Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children
    Karron, Ruth A.
    Atwell, Jessica E.
    McFarland, Elizabeth J.
    Cunningham, Coleen K.
    Muresan, Petronella
    Perlowski, Charlotte
    Libous, Jennifer
    Spector, Stephen A.
    Yogev, Ram
    Aziz, Mariam
    Woods, Suzanne
    Wanionek, Kimberli
    Collins, Peter L.
    Buchholz, Ursula J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (05) : 594 - 603
  • [30] Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine
    Nogales, Aitor
    Rodriguez, Laura
    Chauche, Caroline
    Huang, Kai
    Reilly, Emma C.
    Topham, David J.
    Murcia, Pablo R.
    Parrish, Colin R.
    Martinez-Sobrido, Luis
    [J]. JOURNAL OF VIROLOGY, 2017, 91 (04)